fda warning letters compounding semaglutide september 2025 and Novo Nordisk Warned of GLP-1 Telehealth Takedown. What's Next? FDA issued a warning letter

GLP-1 medications, like Semaglutide and Tirzepatide , have shown the potential to help people lose between 5% and 15% of their body weight

Choose Ipamorelin if you want quick, targeted results such as muscle growth, improved athletic performance, or rapid fat loss

The future likely holds additional options

This disclosure is provided in accordance with FTC 16 CFR Part 255 (Guides Concerning the Use of Endorsements and Testimonials in Advertising)

Rodrigo Mansur, psychiatrist and associate professor who studies mental health at the University of Toronto, describes how the diversity of mental health complicates matters further